HopeStage
Back to overview

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Topics
More filters
27277studies shown
Showing 7,153-7,164 of 27,277
Drug study icon
CompletedNCT02192931

A Controlled study of Creatine in Female Methamphetamine Users

Official study title

A Randomized Double-Blind Controlled Trial of Creatine in Female Methamphetamine Users

This study has finished and is no longer accepting participants.

In Salt Lake City
Addiction, DepressionMedication studyAges 18–55
Countries
United States
Sponsor
Perry Renshaw
Drug study icon
CompletedNCT02192723

A study With 6 Antipsychotic Drugs for Schizophrenia

Official study title

Effectiveness of 6 Antipsychotic Drugs in the Treatment of Acute Exacerbations of Chronic Inpatients With Schizophrenia: a Randomized Double-blind Study

This study has finished and is no longer accepting participants.

In Beijing
SchizophreniaMedication studyAges 25–60
Countries
China
Sponsor
Beijing HuiLongGuan Hospital
Drug study icon
Active Not RecruitingNCT07172516

Azetukalner for depression in bipolarity

What is this study about?

Researchers are comparing Azetukalner and placebo to find out how the approaches affect depression symptoms in people with bipolarity type I or II during a depressive episode.

This study is no longer accepting new participants.

Multiple locations, including Tucson
Bipolarity, DepressionMedication studyAges 18–74
Countries
United States, Bulgaria, Germany, + 1 other
Sponsor
Xenon Pharmaceuticals Inc.
Drug study icon
Active Not RecruitingNCT06775379

A Study of Azetukalner Versus Placebo in Major Depressive Disorder

What is this study about?

Researchers are comparing Azetukalner and placebo to find out how the approaches affect depression symptoms in people with depression.

This study is no longer accepting new participants.

Multiple locations, including Phoenix
DepressionMedication studyAges 18–74
Countries
United States
Sponsor
Xenon Pharmaceuticals Inc.
Drug study icon
Active Not RecruitingNCT07076407

A Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)

What is this study about?

Researchers are comparing Azetukalner and placebo to find out how the approaches affect depression symptoms in people with depression.

This study is no longer accepting new participants.

Multiple locations, including Dothan
DepressionMedication studyAges 18–74
Countries
United States, Finland, Germany, + 4 others
Sponsor
Xenon Pharmaceuticals Inc.
Behavioral study icon
CompletedNCT02685943

A study for Suicidal Patients

Official study title

"Collaborative Assessment and Management of Suicidality" (CAMS) in Comparison to "Treatment as Usual" (TAU) for Suicidal Patients: a Randomized Controlled Trial

This study has finished and is no longer accepting participants.

In Drammen
SuicidalityBehavioural studyAges 18 months+
Countries
Norway
Sponsor
Vestre Viken Hospital Trust

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.